At Dolon, our specialist knowledge in rare diseases is our greatest asset and we want to share that with our clients. Below, we invite you to explore some examples of how we can work with you to translate our knowledge and expertise into effective insights and tools to support your rare disease portfolio.
- Burden of illness assessment & evidence generation
- Market access environment & policy engagement
- Ultra-orphan drug pricing strategy
- Bespoke analytics & financial planning tools
- Value messaging & launch support
- Multi-stakeholder interactive and educative pricing exercise
Please view some of our recent publications.